Primary Site >> Colorectal Cancer
Gene >> TSC1
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Characterizing mutations in samples with low-level mosaicism by collection and analysis of DHPLC fractionated heteroduplexes. PMID: 12552557 |
Ref: Malignant perivascular epithelioid cell tumor of the colon: report of a case with molecular analysis. PMID: 16398680 Ref: Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. PMID: 16969489 |
Ref: Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. PMID: 17671177 |
Ref: Carbachol induces p70S6K1 activation through an ERK-dependent but Akt-independent pathway in human colonic epithelial cells. PMID: 19615971 |
Ref: Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. PMID: 20622004 |
Ref: Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment. PMID: 21999454 |
Ref: Identification of differential gene expressions in colorectal cancer and polyp by cDNA microarray. PMID: 22363125 |
Ref: Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer. PMID: 24770722 |
Ref: PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer. PMID: 26844273 |
Ref: Screening organometallic thiophene containing thiosemicarbazone ruthenium (II/III) complexes as potential anti-tumour agents. PMID: 29569084 Ref: Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data. PMID: 29755661 |